RICI HEALTH (01526) intends to repurchase shares worth up to 1 billion Hong Kong dollars.

date
22:35 17/06/2026
avatar
GMT Eight
Rui Ci Medical (01526) announced that the board of directors has been granted general authorization by the company's shareholders at the company's annual general meeting held on June 17, 2026, to repurchase up to a maximum of 10% of the total number of issued shares of the company as of the date of the 2026 annual general meeting (excluding treasury shares).
RICI HEALTH (01526) announced that the Board of Directors has been granted a general mandate by the company's shareholders at the annual general meeting held on June 17, 2026, to repurchase up to 10% of the total number of issued shares of the company (excluding treasury shares) on the date of the shareholders' annual general meeting in 2026. The Board of Directors has approved a resolution for the company to repurchase shares within the authorized scope with its own funds (excluding any proceeds raised on the main board of The Stock Exchange of Hong Kong Limited) up to a total amount of HK$100 million. The repurchase period will be from the date of Board approval until the conclusion of the next annual general meeting of shareholders in 2027. The company plans to treat the repurchased shares as treasury shares, which may be cancelled, sold, or transferred (including transfers under equity incentive plans) as needed in the future. The Board of Directors has considered the stability of the company's current business operations, the sustainability of its financial profitability, its strong confidence in future growth prospects, and the company's stock market performance and valuation. The Board believes that the current market value of the company's shares is lower than their intrinsic value. In order to effectively maintain the company's value and protect the rights of all shareholders, as well as demonstrate management's long-term confidence in the company's development, the Board recommends implementing the share repurchase program. The Board believes that the share repurchase not only reflects a high recognition of the company's intrinsic value, but also demonstrates sufficient confidence in the long-term prospects of the business. This will ultimately enhance the company's value proposition and create long-term and stable returns for shareholders, which is in line with the overall interests of the company and its shareholders.